RenovoRx, Inc. (RNXT) Insider Trading
Directors, officers and holders of more than 10% of RNXT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 63 transactions on file: 25 with code P, 0 with code S and 25 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Marton Laurence | Director | A Award | 55,924 | Not measured | Not measured |
| Oct 1, 2026 | Macfarlane K. Angela | Director | A Award | 55,924 | Not measured | Not measured |
| Oct 1, 2026 | Spiegel Robert J. | Director | A Award | 55,924 | Not measured | Not measured |
| Oct 1, 2026 | RYAN UNA S | Director | A Award | 55,924 | Not measured | Not measured |
| Sep 10, 2026 | VOLL MARK | Chief Financial Officer | A Award | 80,000 | Not measured | Not measured |
| May 19, 2026 | VOLL MARK | Chief Financial Officer | P Purchase | 25,000 | $0.7876 | $19,690 |
| Apr 3, 2026 | Bagai Shaun | Chief Executive Officer | A Award | 946,107 | Not measured | Not measured |
| Apr 3, 2026 | Gentry Leesa | Chief Clinical Officer | A Award | 128,550 | Not measured | Not measured |
| Apr 3, 2026 | VOLL MARK | Chief Financial Officer | A Award | 80,000 | Not measured | Not measured |
| Apr 3, 2026 | Agah Ramtin | Chief Medical Officer | A Award | 621,727 | Not measured | Not measured |
| Mar 25, 2026 | VOLL MARK | Chief Financial Officer | A Award | 12,380 | Not measured | Not measured |
| Mar 20, 2026 | VOLL MARK | Chief Financial Officer | P Purchase | 48,600 | Not measured | Not measured |
| Mar 20, 2026 | Bagai Shaun | Chief Executive Officer | P Purchase | 24,300 | Not measured | Not measured |
| Mar 20, 2026 | Marton Laurence | Director | P Purchase | 9,720 | Not measured | Not measured |
| Mar 20, 2026 | VOLL MARK | Chief Financial Officer | P Purchase | 97,200 | Not measured | Not measured |
| Mar 20, 2026 | Marton Laurence | Director | P Purchase | 4,860 | Not measured | Not measured |
| Mar 20, 2026 | Bagai Shaun | Chief Executive Officer | P Purchase | 12,150 | Not measured | Not measured |
| Jan 21, 2026 | Agah Ramtin | Chief Medical Officer | P Purchase | 10,000 | $0.9975 | $9,975 |
| Dec 31, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 9,795 | $0.8600 | $8,424 |
| Dec 30, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 205 | $0.8260 | $169 |
| Dec 18, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 5,000 | $0.9013 | $4,507 |
| Dec 17, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 5,000 | $0.8524 | $4,262 |
| Dec 16, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 12,000 | $0.8500 | $10,200 |
| Dec 5, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 10,000 | $0.9600 | $9,600 |
| Nov 24, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 12,000 | $0.8000 | $9,600 |
| Nov 21, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 10,000 | $0.8000 | $8,000 |
| Oct 1, 2025 | Marton Laurence | Director | A Award | 47,640 | Not measured | Not measured |
| Oct 1, 2025 | Spiegel Robert J. | Director | A Award | 47,640 | Not measured | Not measured |
| Oct 1, 2025 | Macfarlane K. Angela | Director | A Award | 47,640 | Not measured | Not measured |
| Oct 1, 2025 | RYAN UNA S | Director | A Award | 47,640 | Not measured | Not measured |
| Aug 25, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 5,000 | $0.9098 | $4,549 |
| Aug 22, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 5,000 | $0.9495 | $4,748 |
| Jul 1, 2025 | Agah Ramtin | Chief Medical Officer | A Award | 63,636 | Not measured | Not measured |
| Jul 1, 2025 | Kocak Ron | VP Controller and PAO | A Award | 41,600 | Not measured | Not measured |
| Jul 1, 2025 | Gentry Leesa | Chief Clinical Officer | A Award | 6,619 | Not measured | Not measured |
| Jul 1, 2025 | Bagai Shaun | Chief Executive Officer | A Award | 102,498 | Not measured | Not measured |
| Jun 5, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 21,000 | $1.40 | $29,400 |
| May 2, 2025 | Marton Laurence | Director | M Exercise | 20,480 | $0.1500 | $3,072 |
| May 2, 2025 | Marton Laurence | Director | M Exercise | 20,480 | Not measured | Not measured |
| Apr 22, 2025 | Agah Ramtin | Chief Medical Officer | G Gift | 400,000 | Not measured | Not measured |
| Apr 15, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 15,000 | $0.9000 | $13,500 |
| Apr 15, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 7,500 | $0.9095 | $6,821 |
| Apr 14, 2025 | Bagai Shaun | Chief Executive Officer | A Award | 409,992 | Not measured | Not measured |
| Apr 14, 2025 | Agah Ramtin | Chief Medical Officer | A Award | 254,542 | Not measured | Not measured |
| Apr 14, 2025 | Gentry Leesa | Chief Clinical Officer | A Award | 26,477 | Not measured | Not measured |
| Apr 14, 2025 | Kocak Ron | VP Controller and PAO | A Award | 166,400 | Not measured | Not measured |
| Apr 11, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 20,000 | $0.8000 | $16,000 |
| Apr 10, 2025 | Kocak Ron | VP Controller and PAO | P Purchase | 6,500 | $0.7900 | $5,135 |
| Apr 9, 2025 | Agah Ramtin | Chief Medical Officer | P Purchase | 30,000 | $0.8133 | $24,399 |
| Apr 9, 2025 | Bagai Shaun | Chief Executive Officer | P Purchase | 10,000 | $0.8300 | $8,300 |
The full Form 4 history is on the RNXT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.